https://www.selleckchem.com/pr....oducts/abbv-cls-484.
Our findings indicate that meiotic drive systems can be maintained for long evolutionary timespans.After market exclusivity ends for biologic drugs, biosimilars-follow-on versions made by other manufacturers-can compete with lower prices. Biosimilars have modestly reduced prescription drug spending for US payers, but it is unclear whether patients have directly experienced any savings. In this study we assessed whether availability of biosimilar infliximab was associated with lower out-of-pocket (OOP) costs, using claims from a nat
Like
Comment
Share
